According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the...
from NDTV News - World-news https://ift.tt/VXcjuWv
Monday, February 7, 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment